GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: mCLB073 | TBD11
Compound class:
Synthetic organic
Comment: CLB073 is an agonist of the Mycobacterium tuberculosis adenylyl cyclase Rv1625c [1].
|
|
No information available. |
Summary of Clinical Use ![]() |
Phase 1 trial is recruiting. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT06707142 | A Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, and Behavior in the Body of TBD11 | Phase 1 Interventional | Bill & Melinda Gates Medical Research Institute |